Author

Mansour M. Alourfi

Observed names: Mansour Alourfi, Mansour Marzouq Alourfi

Institution: Soliman Fakeeh Hospital

Observed institutions: King Abdulaziz University, Soliman Fakeeh Hospital, East Jeddah Hospital

ORCID: 0000-0002-8417-6155

Observed ORCID: 0000-0002-8417-6155

OpenAlex ID: A5035422281

A cross-sectional survey on the psychological impact of the COVID-19 pandemic on inflammatory bowel disease patients in Saudi Arabia

2020 · Mahmoud Mosli, Mansour Alourfi, et al. · Saudi Journal of Gastroenterology · 40

NAFLD and nutraceuticals: a review of completed phase III and IV clinical trials

2023 · Omar E. Hegazi, Samer O. Alalalmeh, et al. · Frontiers in Medicine · 16

Exploring Promising Therapies for Non-Alcoholic Fatty Liver Disease: A ClinicalTrials.gov Analysis

2024 · Omar Hegazi, Samer Alalalmeh, et al. · Diabetes Metabolic Syndrome and Obesity · 9

Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis

2022 · Nasser M Alorfi, Mansour Marzouq Alourfi · Biologics · 8

A Rare Case of Adult Dysphagia: Dysphagia Lusoria

2020 · Mansour Alourfi, Mahmoud Mosli · ACG Case Reports Journal · 7

Comprehensive Review of Ustekinumab Utilization in Inflammatory Bowel Diseases: Insights from the ClinicalTrials.gov Registry

2023 · Nasser Alorfi, Mansour Alourfi, et al. · International Journal of General Medicine · 5

Pharmacovigilance of semaglutide: A descriptive analysis of WHO-VigiAccess reports

2026 · Nasser M. Alorfi, Mansour M. Alourfi, et al. · Medicine · 2

The Efficacy of Anti-Tumor Necrosis Factor Alpha for Symptomatic Stricturing Small Bowel Crohn’s Disease

2020 · Mansour Alourfi, Mahmoud Mosli, et al. · Cureus · 2

Readiness for precision medicine: pharmacogenomic literacy among adults surveyed in the United Arab Emirates: a cross-sectional study

2026 · Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, et al. · Journal of Community Genetics

Translation, cultural adaptation, and validation of the perceived Artificial Intelligence Literacy Questionnaire-6 (PAILQ-6) in Arabic-speaking pharmacists: A cross-sectional methodological study

2026 · Ammar Abdulrahman Jairoun, Moyad Shahwan, et al. · Exploratory Research in Clinical and Social Pharmacy

Global pharmacovigilance overview of adverse drug reactions associated with propofol: A descriptive pharmacovigilance study using WHO-VigiAccess data

2026 · Nasser M. Alorfi, Ammar Aldabbagh, et al. · Medicine

Characteristics of Completed ClinicalTrials.gov Trials Investigating Neurogenic Bowel Dysfunction Among Individuals with Neurological Disabilities: A Registry-based Analysis

2026 · Nasser M. Aldekhail, Hanan Khojah, et al. · Journal of Disability Research

Emerging Therapies in Primary Biliary Cholangitis: Overview of Clinicaltrials.gov

2023 · Nasser Alorfi, Mansour Alourfi, et al. · Bulletin of Pharmaceutical Sciences Assiut

IDDF2022-ABS-0062 Diagnostic delay of Crohn’s disease in Saudi Arabia: predictors and association with disease complications

2022 · Mansour Alourfi, Mahmoud Mosli, et al. · Gut

Works count: 14

Citation count: 89

H-index: 5

I10-index: 2